Background: Congenital cystic adenomatoid malformation of the lung (CCAM) is an
embryonic developmental anomaly of an unknown etiology usually diagnosed antenatally by …

Background Whole genome sequencing provides better delineation of transmission clusters
in Mycobacterium tuberculosis than traditional methods. However, its ability to reveal …

The frequency of allergic diseases has increased in recent decades. Asthma is one of the
most prevalent conditions and a leading cause of morbidity. It affects 3-4% of the population in …

Purpose. To establish the prevalence of bronchiectasis in asthma in relation to patients’ oral
corticosteroid requirements and to explore whether the increased risk is due to blood …

Introduction: Omalizumab is a monoclonal antibody that binds and inhibits free serum
immunoglobulin E, a mediator involved in the clinical manifestations of allergic asthma. Evidence …

Transmission is a driver of tuberculosis (TB) epidemics in high-burden regions, with assumed
negligible impact in low-burden areas. However, we still lack a full characterization of …

We compared the bacterial microbiomes lodged in the bronchial tree, oropharynx and nose
of patients with early stage cystic fibrosis (CF) not using chronic antibiotics, determining their …

Background In June, 2021, WHO published the most complete catalogue to date of
resistance-conferring mutations in Mycobacterium tuberculosis. Here, we aimed to assess the …

Objectives Infants with cow's milk allergy (CMA) are in need of a substitute formula up to 2
years. The are three requisites for a substitute of milk in CMA: tolerability, nutritional adequacy, …

Background Various studies have assessed omalizumab outcomes in the clinical practice
setting but follow‐up and/or number of patients included were limited. We aim to describe the …